Seasonal Influenza and Pneumococcal vaccination compliance among inpatients and outpatients at The Queen Elizabeth Hospital: A cross – Sectional study

Autor: Yasamin Veziari, Marija Juraja, Amber Heitmann
Přispěvatelé: Juraja, Marija, Heitmann, Amber, Veziari, Yasamin
Rok vydání: 2016
Předmět:
Zdroj: Infection, Disease & Health. 21:97-107
ISSN: 2468-0451
DOI: 10.1016/j.idh.2016.09.001
Popis: Background Patient compliance with seasonal influenza is important when they are one of the most at risk population within the healthcare setting. Secondary to this is compliance or even awareness of the importance in Pneumococcal vaccine compliance among the patients who are 65 or above, or in Indigenous groups 50 and above. Objective To examine the uptake and factors that may be influencing non-compliance of Influenza and Pneumococcal vaccine among hospital and nonhospital patients. Design & setting Small cross sectional study. A vaccine compliance questionnaire was administered to patients in different hospital settings between May and June 2015 at The Queen Elizabeth Hospital (TQEH), South Australia. Population A total of 202 inpatients and outpatients at TQEH aged from 15 and above. Material and methods De-identified paper surveys were used to assess compliance with the annual Influenza vaccine and to examine factors that predicted the uptake of the vaccine. Compliance with the Pneumococcal vaccine was also surveyed. Results In all, 202 patients completed the survey. The deterrents of vaccination were perceived illness of vaccine adverse effects, and scepticism. The strongest predictor of compliance for both vaccines was age. Conclusion As this was a small sample size it makes it difficult to generalize the results. Overall, the vaccine uptake was higher in the 65 and above age group. Vaccine compliance among outpatients and inpatients differed. Targeted interventions should be aimed to increase vaccine awareness and compliance in the vulnerable population i.e. pregnant or immunocompromised individuals. The rationale for this is possibly the cost of the vaccine and the perceived risk of acquisition of the disease. Refereed/Peer-reviewed
Databáze: OpenAIRE